```html

Huntington’s Disease: A Patient‑Friendly Medical Guide

Overview

Huntington’s disease (HD) is a progressive, inherited neurodegenerative disorder that leads to the gradual loss of brain cells, primarily in the basal ganglia and cerebral cortex. The disease manifests with a characteristic triad of motor, cognitive, and psychiatric symptoms.

HD affects people of all ethnicities but is most common in people of European descent. It typically appears in mid‑adulthood, although juvenile forms exist.

• Prevalence: Approximately 12–15 per 100,000 people of European ancestry carry the defective gene, and 5–7 per 100,000 develop symptoms. Worldwide prevalence is estimated at ~6 per 100,000, with higher rates in North America and Europe. [1][2]
• Age of onset: Median onset is around 35–44 years; however, onset can range from childhood to the 70s.
• Inheritance: Autosomal‑dominant; each child of an affected parent has a 50 % chance of inheriting the mutation.

Symptoms

Symptoms develop slowly and progressively. They are grouped into three domains.

Motor (movement) symptoms

• Chorea: Involuntary, jerky, dance‑like movements that affect the face, limbs, trunk, and mouth.
• Dystonia: Sustained muscle contractions causing abnormal postures.
• Impaired coordination (ataxia): Difficulty with balance, walking, and fine motor tasks.
• Bradykinesia: Slowness of movement, similar to Parkinson’s disease.
• Speech & swallowing problems (dysarthria & dysphagia): Slurred speech, difficulty chewing or swallowing.
• Oculomotor abnormalities: Jerky eye movements or difficulty tracking objects.

Cognitive symptoms

• Executive dysfunction: Trouble planning, organizing, and problem‑solving.
• Memory impairment: Particularly for recent events; long‑term memory is relatively preserved early on.
• Reduced concentration: Easier to become distracted.
• Difficulty with insight: Patients may lack awareness of their deficits (anosognosia).

Psychiatric & behavioral symptoms

• Depression & anxiety: Very common; can precede motor signs.
• Irritability & aggression: May manifest as sudden outbursts.
• Obsessive‑compulsive behaviors: Repetitive thoughts or actions.
• Psychosis: Delusions or hallucinations in later stages.
• Suicidal thoughts or attempts: Occur in up to 10 % of patients; urgent attention required.

Symptoms typically appear in the order: mood changes → subtle motor signs → cognitive decline, but individual patterns vary.

Causes and Risk Factors

Genetic cause

HD is caused by an expanded CAG trinucleotide repeat in the HTT gene on chromosome 4. Normal alleles contain 10–35 repeats; disease‑causing alleles have ≥36 repeats. The larger the repeat number, the earlier the onset and the more rapid the progression (the phenomenon of anticipation).

Risk factors

• Family history: A parent with HD confers a 50 % risk to each child.
• Repeat length: >60 repeats usually produce juvenile onset; 36‑39 repeats can result in reduced penetrance.
• Ethnicity: Higher carrier frequency in people of European descent.
• Age: While the mutation is present from birth, symptoms typically emerge between ages 30–50.

Non‑genetic contributors

Environmental factors (e.g., head trauma, lifestyle) have not been shown to cause HD, but they may influence symptom severity. Maintaining physical activity and mental stimulation is associated with slower functional decline, although these are supportive rather than preventive.

Diagnosis

Clinical evaluation

Diagnosis begins with a thorough history (including family pedigree) and neurological exam focusing on chorea, gait, speech, and cognitive testing.

Genetic testing

• DNA analysis: Detects the number of CAG repeats in the HTT gene. A repeat length ≥36 confirms the diagnosis.
• Predictive testing: Offered to at‑risk relatives who have no symptoms; must be performed with pre‑ and post‑test counseling.

Neuroimaging

• MRI or CT: Shows progressive atrophy of the caudate nucleus and putamen; useful for ruling out other causes.
• Functional imaging (PET, SPECT): May detect metabolic changes before atrophy is apparent but is not required for diagnosis.

Additional assessments

• Neuropsychological testing for baseline cognition.
• Psychiatric evaluation to identify depression, anxiety, or psychosis.
• Blood work to exclude treatable mimics (e.g., thyroid disease, Wilson’s disease).

Treatment Options

There is currently no cure for HD; therapy focuses on symptom control, improving quality of life, and slowing functional decline.

Medications

• Tetrabenazine (Xenazine) or Deutetrabenazine (Austedo): First‑line agents for chorea; work by depleting dopamine. Common side effects include depression and parkinsonism.
• Antipsychotics (e.g., risperidone, olanzapine, haloperidol): Helpful for severe chorea, aggression, or psychosis.
• Antidepressants (SSRIs, SNRIs): Treat depression, anxiety, and obsessive‑compulsive symptoms.
• Mood stabilizers (valproic acid, carbamazepine): For mood swings or irritability.
• Amantadine: May modestly improve motor symptoms.

Procedural & supportive therapies

• Physical therapy: Maintains strength, balance, and gait; reduces fall risk.
• Occupational therapy: Adapts home/work environments, teaches energy‑conservation strategies.
• Speech‑language therapy: Addresses dysarthria, swallowing difficulties, and communication strategies.
• Deep brain stimulation (DBS): Experimental for severe chorea; limited data, generally reserved for refractory cases.

Lifestyle & self‑care measures

• Regular aerobic exercise: Improves motor function and mood.
• Cognitive stimulation: Puzzles, learning new skills, and social interaction may preserve cognition.
• Balanced diet: Adequate calories and protein to counter weight loss; consider soft or pureed foods if dysphagia develops.
• Safety modifications: Grab bars, non‑slip mats, and adaptive utensils reduce injury.
• Support groups & counseling: Emotional support for patients and caregivers is essential.

Living with Huntington’s Disease

Daily management tips

1. Create a routine: Predictable schedules lessen anxiety and conserve energy.
2. Use assistive devices early: Canes, walkers, or motorized scooters when gait becomes unstable.
3. Plan for medication adherence: Pill organizers, alarms, or caregiver supervision.
4. Monitor nutrition and weight: Record food intake; consult a dietitian if weight loss exceeds 5 % of body weight.
5. Maintain oral health: Dental check‑ups prevent infections that can exacerbate swallowing problems.
6. Legal & financial planning: Establish advance directives, power of attorney, and discuss long‑term care options while capacity is intact.
7. Caregiver respite: Use home‑health aides or adult‑day programs to prevent burnout.

Psychosocial support

• Join Huntington’s disease societies (e.g., HDSA) for peer mentoring.
• Engage in psychotherapy, especially cognitive‑behavioral therapy for depression or anxiety.
• Consider genetic counseling for family planning and testing of relatives.

Prevention

Because HD is a monogenic disorder, true prevention is not possible once the mutation is present. However, the following steps can reduce secondary risks and improve outcomes:

• Genetic counseling: Enables informed reproductive choices (pre‑implantation genetic diagnosis, prenatal testing).
• Healthy lifestyle: Regular exercise, balanced nutrition, and avoidance of smoking or excessive alcohol can mitigate cardiovascular comorbidities that compound disability.
• Early detection: Prompt genetic testing in at‑risk individuals allows earlier symptom management, which may slow functional decline.

Complications

If left untreated or inadequately managed, HD can lead to serious complications that impact survival.

• Falls & fractures: Due to chorea, balance deficits, and muscle weakness.
• Pneumonia: Aspiration from dysphagia is a leading cause of death.
• Malnutrition & weight loss: Resulting from feeding difficulties and high energy expenditure.
• Cardiovascular disease: Autonomic dysfunction may cause arrhythmias.
• Severe depression or suicide: Requires immediate psychiatric intervention.
• Legal and financial crises: Loss of employment and mounting care costs.

When to Seek Emergency Care

References

1. Mayo Clinic. Huntington’s disease - Symptoms and causes. https://www.mayoclinic.org
2. Centers for Disease Control and Prevention. Huntington Disease Fact Sheet. https://www.cdc.gov
3. National Institute of Neurological Disorders and Stroke. Huntington’s Disease Fact Sheet. https://www.ninds.nih.gov
4. World Health Organization. Genetic counselling and testing. https://www.who.int
5. Cleveland Clinic. Huntington’s disease treatment options. https://my.clevelandclinic.org
6. Huntington’s Disease Society of America. Caregiver resources. https://hdsa.org

```